Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Pharynx

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   43881   clinical trials with a EudraCT protocol, of which   7295   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    64 result(s) found for: Pharynx. Displaying page 1 of 4.
    1  2  3  4  Next»
    EudraCT Number: 2011-002542-12 Sponsor Protocol Number: IEOS629/411 Start Date*: 2012-09-19
    Sponsor Name:ISTITUTO EUROPEO DI ONCOLOGIA
    Full Title: Lymphatic mapping in oropharyngeal neoplasms: comparison between Dynamic Lymphoscintigrafy and Fluorescence Lymphografy using indocyanine green dye (ICG). Validation study.
    Medical condition: - Epithelial Carcinoma of the oral cavity and oropharynx
    Disease: Version SOC Term Classification Code Term Level
    14.1 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10034819 Pharyngeal cancer stage unspecified PT
    14.1 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10024534 Lip and/or oral cavity cancer NOS LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2017-000353-39 Sponsor Protocol Number: CONFRONT Start Date*: 2018-05-02
    Sponsor Name:G.O.N.O. - GRUPPO ONCOLOGICO DEL NORD OVEST
    Full Title: The CONFRONT Phase I – II Trial: ACtivatiON oF immune RespONse in paTients with R-M Head and Neck Cancer. Multimodality immunotherapy with Avelumab, short course radiotherapy and Cyclophosphamide i...
    Medical condition: R-M Head and Neck Cancer
    Disease: Version SOC Term Classification Code Term Level
    20.0 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10034813 Pharyngeal cancer recurrent PT
    20.0 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10055104 Pharyngeal cancer metastatic PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2005-002250-21 Sponsor Protocol Number: 044(D)SC04158 Start Date*: 2005-05-31
    Sponsor Name:ANGELINI
    Full Title: EVALUATION OF ANTALGIC EFFECT AND TOLERABILITY OF A NEW PARACETAMOL SYRUP DOSAGE IN PHARINGOTONSILLYTIS IN PEDIATRY. DOUBLE-BLIND VS PLACEBO STUDY, CONTROLLED VS KETOPROFEN LYSINA SALT.
    Medical condition: ANTALGIC EFFECT AND TOLERABILITY OF A NEW DOSAGE OF PARACETAMOL SYRUP IN PHARINGOTONSILLYTIS IN PEDIATRY
    Disease: Version SOC Term Classification Code Term Level
    6.1 10034835 PT
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: View results
    EudraCT Number: 2017-002349-30 Sponsor Protocol Number: cod2017 Start Date*: 2017-09-12
    Sponsor Name:TARGID, KU Leuven
    Full Title: Effect of codeine on pharyngeal and esophageal motility in healthy subjects: a double-blind, placebo-controlled, randomized, cross-over study
    Medical condition: we will investigate the effect of codeine on motility in the pharynx and esophagus in healthy subjects
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: BE (Completed)
    Trial results: View results
    EudraCT Number: 2011-000278-74 Sponsor Protocol Number: KKL022010 Start Date*: 2011-07-11
    Sponsor Name:KRKA, tovarna zdravil, d. d., Novo mesto
    Full Title: A COMPARATIVE EFFICACY AND SAFETY OF CETYLPYRIDINIUM CHLORIDE 1.0 mg/BENZYDAMINE HYDROCHLORIDE 3 mg FIXED COMBINATION LOZENGES IN SUBJECTS WITH SORE THROAT ASSOCIATED WITH UPPER RESPIRATORY TRACT I...
    Medical condition: Sore throat associated with upper respiratory infections
    Disease: Version SOC Term Classification Code Term Level
    14.0 10038738 - Respiratory, thoracic and mediastinal disorders 10041368 Sore throat NOS LLT
    14.0 10038738 - Respiratory, thoracic and mediastinal disorders 10068319 Oropharyngeal pain PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SI (Completed)
    Trial results: View results
    EudraCT Number: 2008-003840-13 Sponsor Protocol Number: UNITHER/UN/07/002 Start Date*: 2008-12-17
    Sponsor Name:UNITHER Pharmaceuticals
    Full Title: Essai clinique comparant l'efficacité et la tolérance d'un comprimé à sucer contenant 14,63 mg d'Ibuprofène versus placebo
    Medical condition: Angines
    Disease: Version SOC Term Classification Code Term Level
    10.0 10041367 LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2010-024045-69 Sponsor Protocol Number: TH1017 Start Date*: 2011-01-11
    Sponsor Name:Reckitt Benckiser Healthcare
    Full Title: A multi centre, randomised, double blind, single dose parallel group, placebo controlled study to investigate the efficacy of Strepsils Plus and Strepsils Extra in the treatment of sore throat due ...
    Medical condition: Sore throat due to upper respiratory tract infection
    Disease: Version SOC Term Classification Code Term Level
    12.1 10041367 sore throat LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2010-021653-39 Sponsor Protocol Number: 075-A-301 Start Date*: 2010-12-08
    Sponsor Name:Novartis Consumer Health S.A.
    Full Title: A randomized, double-blind, parallel group, single-dose study of the efficacy of lidocaine 8 mg + cetylpyridinium chloride (CPC) 2 mg fixed combination lozenges on sore throat pain intensity compar...
    Medical condition: Sore throat due to upper respiratory tract infection (Planned indication for approval: Local antiseptic and analgesic treatment of sore throat and minor infections of the mouth. Relief of pain as ...
    Disease: Version SOC Term Classification Code Term Level
    12.1 10041367 Sore throat LLT
    12.1 10068319 Oropharyngeal pain LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2010-020985-94 Sponsor Protocol Number: TH1010 Start Date*: 2010-09-10
    Sponsor Name:Reckitt Benckiser Healthcare (UK) Ltd
    Full Title: A randomised, double blind, placebo-controlled, parallel group, single dose study of the efficacy of a flavoured variant of Strepsils Throat Lozenge in the relief of dry and irritated sore throat d...
    Medical condition: Sore throat
    Disease: Version SOC Term Classification Code Term Level
    12.1 10041367 Sore throat LLT
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2008-005059-67 Sponsor Protocol Number: TH0809 Start Date*: 2008-11-04
    Sponsor Name:Reckitt Benckiser Healthcare UK Ltd
    Full Title: A multi-centre, randomised, double blind, placebo-controlled, parallel group, single dose, pilot study of the efficacy of 0.6 mg Amylmetacresol BP (AMC) and 1.2mg 2,4-Dichlorobenzyl alcohol (DCBA) ...
    Medical condition: Sore throat
    Disease: Version SOC Term Classification Code Term Level
    9.1 10041367 Sore throat LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2008-005596-10 Sponsor Protocol Number: TH0817 Start Date*: 2008-12-05
    Sponsor Name:Reckitt Benkiser Healthcare (UK) Ltd
    Full Title: A multi centre, randomised, double blind, placebo-controlled, parallel group, single dose study of the efficacy of two flavour variants of Strepsils throat lozenges in the relief of sore throat due...
    Medical condition: Sore Throat
    Disease: Version SOC Term Classification Code Term Level
    9.1 10041367 Sore throat LLT
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2006-006769-17 Sponsor Protocol Number: TH0612 Start Date*: 2007-04-18
    Sponsor Name:Reckitt Benckiser Healthcare International Ltd
    Full Title: A randomised, controlled, open-label, single-centre, parallel group, pilot study to investigate the onset of action of a lozenge compared with a caplet in patients with sore throat.
    Medical condition: patients with sore throat
    Disease: Version SOC Term Classification Code Term Level
    9.1 10041367 Sore throat LLT
    Population Age: Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2007-004375-19 Sponsor Protocol Number: TH0705 Start Date*: 2007-10-26
    Sponsor Name:Reckitt Benckiser Healthcare
    Full Title: A multi-centre, randomised, double-blind, parallel-group, placebo-controlled, multiple dose study of the efficacy of Strepsils original throat lozenges in the relief of sore throat due to upper res...
    Medical condition: Sore throat
    Disease: Version SOC Term Classification Code Term Level
    9.1 10041367 Sore throat LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2013-002970-32 Sponsor Protocol Number: KKL072012 Start Date*: 2013-12-23
    Sponsor Name:KRKA, tovarna zdravil, d. d., Novo mesto
    Full Title: A COMPARISON OF THERAPEUTIC EQUIVALENCE BETWEEN THE TEST AND THE REFERENCE FORMULATION OF FIXED COMBINATION OF CETYLPYRIDINIUM CHLORIDE 1.0 mg/BENZYDAMINE HYDROCHLORIDE 3 mg IN SUBJECTS WITH SORE T...
    Medical condition: Sore throat associated with upper respiratory infections
    Disease: Version SOC Term Classification Code Term Level
    16.1 10038738 - Respiratory, thoracic and mediastinal disorders 10041368 Sore throat NOS LLT
    16.1 10038738 - Respiratory, thoracic and mediastinal disorders 10068319 Oropharyngeal pain PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SI (Completed)
    Trial results: View results
    EudraCT Number: 2008-008265-36 Sponsor Protocol Number: KETOP_C_03968 Start Date*: 2009-05-26
    Sponsor Name:SANOFI-AVENTIS GROUPE
    Full Title: “A randomised, double-blind, placebo-controlled, parallel-group study of the efficacy and safety of two doses of ketoprofen lysinate lozenges (6.25mg and 12.5mg ) in patients with sore throat”
    Medical condition: upper respiratory illness : sore throat
    Disease: Version SOC Term Classification Code Term Level
    9.1 10041367 Sore throat LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FI (Completed) FR (Completed) DE (Completed) ES (Completed)
    Trial results: View results
    EudraCT Number: 2009-017728-13 Sponsor Protocol Number: globuspregabalin Start Date*: 2010-02-18
    Sponsor Name:UZLeuven
    Full Title: A randomized controlled trial comparing pregabalin and placebo in patients with persistent globus sensation
    Medical condition: Globus symptoms
    Disease: Version SOC Term Classification Code Term Level
    12.1 10051180 Globus feeling in pharynx LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: BE (Completed)
    Trial results: View results
    EudraCT Number: 2020-000886-17 Sponsor Protocol Number: SORETROATH Start Date*: 2020-11-02
    Sponsor Name:FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS UNIVERSITA' CATTOLICA DEL SACRO CUORE
    Full Title: SUBGLOTTIC INSTILLATION OF FLURBIPROFENE TO PREVENT LARYNGEAL INFLAMMATION FOLLOWING ENDOTRACHEAL INTUBATION: PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED PILOT STUDY
    Medical condition: Sore throat generally associated with cough and hoarseness after orotracheal intubation.
    Disease: Version SOC Term Classification Code Term Level
    23.1 100000004855 10041367 Sore throat LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2013-003622-86 Sponsor Protocol Number: CA209-141 Start Date*: 2014-06-05
    Sponsor Name:Bristol-Myers Squibb International Corporation
    Full Title: An Open Label, Randomized Phase 3 Clinical Trial of Nivolumab vs Therapy of Investigator's Choice in Recurrent or Metastatic Platinum-refractory Squamous Cell Carcinoma of the Head and Neck (SCCHN)
    Medical condition: Squamous cell carcinoma of the head and neck
    Disease: Version SOC Term Classification Code Term Level
    16.1 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10066471 Squamous cell carcinoma of pharynx PT
    16.1 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10041857 Squamous cell carcinoma of the oral cavity PT
    16.1 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10023856 Laryngeal squamous cell carcinoma PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed) GB (Completed) ES (Completed) DE (Completed) NL (Completed) FR (Completed)
    Trial results: View results
    EudraCT Number: 2009-014401-13 Sponsor Protocol Number: 030(B)SC09047 Start Date*: 2009-12-15
    Sponsor Name:ANGELINI
    Full Title: Efficacy and safety of an alcohol-free formulation of 0.15% benzydamine spray in children with sore throat. Randomized, double blind, placebo-controlled study
    Medical condition: sore-throat
    Disease: Version SOC Term Classification Code Term Level
    9.1 10057868 LLT
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: IT (Completed) AT (Completed) SK (Completed) RO (Completed) ES (Completed)
    Trial results: View results
    EudraCT Number: 2022-003285-20 Sponsor Protocol Number: 030(Z)MD22061 Start Date*: 2023-03-13
    Sponsor Name:Angelini Pharma S.p.A.
    Full Title: Phase IV study comparing the efficacy and safety of an alcohol-free formulation of 0.15% benzydamine hydrochloride spray and benzydamine hydrochloride 3mg lozenges in paediatric patients (6-12 year...
    Medical condition: acute sore throat
    Disease: Version SOC Term Classification Code Term Level
    23.1 100000004855 10041367 Sore throat LLT
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: HU (Completed) BG (Completed)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  4  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sun May 19 17:41:17 CEST 2024 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA